News

Press Release Issued:
IASIC Opposes the Removal of Cannabis from Schedule 1

BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:

As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.

“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.

An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.

IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.

‘Alarming’ Number of NY Teens are ‘Overdosing’ on Weed in HV

Officials from the Hudson Valley continue to worry after a number of high school students were hospitalized from marijuana use. Last week, several Pine Bush High School students were transported to the hospital due to drug use. “The health consequences were serious, but they have recovered and are getting support from their families,” Pine Bush’s interim

Read More »

Talking to Teens About Cannabis Gummies as Use Booms

Schools and doctors say more teens are getting high at school on candies or cookies containing cannabis. The expanding legalization of recreational marijuana across the U.S. has led to wider availability of cannabis edibles. Their popularity has created vexing problems for educators and families, who say it has become harder to detect teens’ cannabis use.

Read More »

Marijuana Legalization and Opioid Deaths

Over the last two decades there has been considerable movement at the state-level to legalize marijuana, initially for medical purposes and more recently for recreational consumption. Despite prior research, it is unclear how, if at all, these policies are related to rates of opioid-involved overdose deaths, which have trended rapidly upwards over time and represent

Read More »

OUR CHANGED WORLD: ‘A lot of people started using a lot of cannabis’: CMHA says referrals for early psychosis have doubled

Increased cannabis use brought on by the COVID-19 pandemic might be causing more young people to lose grip with reality. “A lot of people started using a lot of cannabis,” according to Dr. Allie Douglas, lead psychiatrist for the Canadian Mental Health Association’s first-step early psychosis intervention program serving Waterloo-Wellington. “The number of people coming

Read More »

Recent Trends in Marijuana-Related Hospital Encounters in Young Children

Multiple states have passed legislation permitting marijuana use. The impact of legalization on trends in hospital encounters for marijuana exposures in young children across states remains unknown. This study, published in Academic Pediatrics in July 2021, aims to describe trends in marijuana-related hospital encounters over time in children <6 years and assess the association of

Read More »

Sentinel Surveillance of Substance-Related Poisonings in Canada: Spotlight on Cannabis

Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations

Read More »

Cannabis and Psychosis: Recent Epidemiological Findings Continuing the “Causality Debate”

Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially among the young, coupled with the increasing potency of cannabis (higher delta-9-tetrahydrocannabinol [THC] content) during this period (3), has raised concerns about the long-term health impact

Read More »

Three Years After Legalization, Canada Has Little Information About How It Changed Cannabis Use and Health Harms

In an editorial piece penned by Public Health Physician and Canadian Institutes of Health Research Fellow Daniel Myran for The Conversation, Dr. Myran explains the lack of timely and current data on recreational cannabis legalization before a mandated review of the health impacts. He cites three main areas that limit the understanding of legalization’s health

Read More »

Listen to podcast High Truths on Drugs and Addiction on your favorite platform. ​Hightruth.com

Most Recent News

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Read More »

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Read More »

IASIC Speaker Series Presents: Case Report on Cannabis-Induced Acute Encephalopathy in Elderly After Taking CBD

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Read More »
Scroll to Top